Innate Pharma IPHA Q1 2026 Earnings Deep EPS Miss Weighs on Shares as Pipeline Progress Remains in Focus Mineralys Therapeutics MLYS Q1 2026 Earnings Narrowerthanexpected Loss as Clinical Progress Continues SIM Q1 2023 Earnings Earnings Miss Surprises Market as Steel Demand Weakens Geron Corporation Q1 2026 Earnings NarrowerThanExpected Loss as Rytelo Commercialization Advances AEHL Q3 2012 Earnings EPS Beats Estimates by 768 Stock Falls Sharply Redwood Trust Inc 900 Senior Notes Due 2029 RWTO Q1 2026 Earnings BottomLine Miss Underscores NearTerm Headwinds